查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
兽药中单克隆抗体的市场规模、份额和趋势分析报告：按用途、动物物种、最终用户、地区和细分市场预测，2023-2030
市场调查报告书
商品编码
1321473

兽药中单克隆抗体的市场规模、份额和趋势分析报告：按用途、动物物种、最终用户、地区和细分市场预测，2023-2030

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

单克隆抗体市场增长和兽药趋势

Grand View Research, Inc.的最新报告显示，到2030年，全球兽药单克隆抗体市场规模预计将达到24.2亿美元，2023年至2030年年复合成长率为17.1%。

宠物数量的增加加上宠物支出的增加预计将推动市场增长。此外，犬特应性皮炎患病率的增加可能会推动预测期内的市场增长。

儘管受到 COVID-19 大流行的影响，兽医保健行业从 2019 年到 2020 年仍实现了 8% 的稳定增长。与其他市场相比，经济衰退对动物保健行业的影响相对较小。疫情给动物医院和兽医的商业模式带来了一些变化。传统兽医医院预计将通过销售生物製剂和药品等高利润产品获得大部分收入。

癌症的增加，尤其是狗的癌症的增加，预计将为市场提供增长基础。根据美国兽医协会 (AVMA) 的数据，四分之一的狗预计会在生命中的某个阶段出现肿瘤迹象。肿瘤是一种常见于狗的癌症。疼痛管理是治疗犬肿瘤最重要的方面之一。这也可以用单克隆抗体来治疗。

市场竞争非常激烈，有几家主要参与者进入该市场。随着市场中巨大机会的出现，市场上的各个参与者都在投资以成为领先者。例如，2021年10月，硕腾在爱尔兰收购了一家新的开发和製造单位，以提高其兽药单克隆抗体（mAb）的产能。

预计这将加强其兽医治疗生物製药的产品组合。此外，2021年8月，Elanco以约4.44亿美元收购了Kindred Biosciences。这帮助Elanco进入皮肤科市场，补充了产品平臺，并增强了其在生物製剂和单克隆抗体方面的研发能力。

此外，2023 年 5 月，Elanco 宣布使用单克隆抗体对致命的犬细小病毒病进行突破性治疗。这种单次静脉注射可以治疗病犬和幼犬中由细小病毒引起的症状，无论是否接种疫苗。

兽药中的单克隆抗体市场报告亮点

  • 从动物类型来看，由于人们越来越多地采用狗作为宠物，以及针对狗疾病治疗的研究和开发的增加，到 2022 年，狗细分市场将占据压倒性的收入份额。我做到了。
  • 从用途来看，由于犬类特应性皮炎的患病率不断增加，皮肤科领域在 2022 年占据了最大的市场份额，超过 50%。
  • 由于兽医医院拥有先进的治疗设施，到 2022 年，兽医医院细分市场将占据最终用户的主导市场份额。
  • 由于该地区存在主要市场参与者，2022 年北美将占据最大市场份额，约为 40%。

目录

第1章调查方法和范围

  • 市场区隔和范围
  • 调查方法
  • 资讯或资料分析
  • 常见调查方法
  • 调查范围和先决条件
  • 市场形成和检验
  • 型号详情
  • 二手资讯清单

第2章执行摘要

第3章市场变量、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/辅助市场预测
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
    • 市场机会分析
    • 市场问题分析
  • 行业分析
    • 搬运工
    • PESTEL
  • 法律规范
  • 产品平臺分析
  • COVID-19 影响分析

第4章兽药单克隆抗体市场：动物种类估算及趋势分析

  • 细分仪表板
  • 兽医单克隆抗体市场：按动物类型分類的变异分析，百万美元，2022 年和 2030 年
  • 狗
  • 其他的

第5章兽药单克隆抗体市场：用途预估及趋势分析

  • 细分仪表板
  • 兽药单克隆抗体市场：用途变化分析，百万美元，2022 年和 2030 年
  • 皮肤科
  • 疼痛
  • 其他的

第6章兽药单克隆抗体市场：最终用户估计和趋势分析

  • 兽药单克隆抗体市场：最终用户变异分析，百万美元，2022 年和 2030 年
  • 动物医院
  • 其他的

第7章兽药单克隆抗体市场：区域估算及趋势分析

  • 兽药单克隆抗体市场：2022 年和 2030 年区域变化分析
  • 北美
    • SWOT分析
    • 2018年至2030年北美兽医单克隆抗体市场估计和预测
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 2018-2030年欧洲兽药单克隆抗体市场估计和预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • SWOT分析
    • 2018-2030年亚太地区兽药单克隆抗体市场预测
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
  • 拉美
    • SWOT分析
    • 2018-2030年拉丁美洲兽医单克隆抗体市场估计和预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • SWOT分析
    • 2018-2030年中东和非洲兽医单克隆抗体市场估计和预测
    • 南非
    • 沙乌地阿拉伯

第8章竞争形势

  • 市场参与分类
  • 主要公司简介
    • Zoetis
    • Merck &Co, Inc.
    • Elanco
    • Boehringer Ingelheim GmbH
    • Indian Immunologicals Ltd
    • Virbac
  • List of Other Players（inclusive of companies with pipeline products）
Product Code: GVR-4-68039-973-5

Monoclonal Antibodies In Veterinary Health Market Growth & Trends

The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.42 billion by 2030, expanding at a CAGR of 17.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company's access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights

  • Based on animal type, the dog segment held the dominant revenue share in 2022 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments
  • Based on the application, the dermatology segment accounted for the largest market share of over 50% in 2022, owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2022, owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North America accounted for the largest market share of around 40% in 2022, owing to the presence of major market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. General Methodology
  • 1.5. Research Scope & Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Bottom-Up & Hybrid Model
    • 1.7.3. CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Industry Analysis
    • 3.3.1. Porter's
    • 3.3.2. PESTEL
  • 3.4. Regulatory Framework
  • 3.5. Product Pipeline Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Monoclonal Antibodies In Veterinary Health Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, USD Million, 2022 & 2030
  • 4.3. Dogs
    • 4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Monoclonal Antibodies In Veterinary Health Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, USD Million, 2022 & 2030
  • 5.3. Dermatology Market
    • 5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain
    • 5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Monoclonal Antibodies In Veterinary Health Market: End-User Estimates & Trend Analysis

  • 6.1. Monoclonal Antibodies In Veterinary Health Market: End-User Movement Analysis, USD Million, 2022 & 2030
  • 6.2. Veterinary Hospitals
    • 6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Others
    • 6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Monoclonal Antibodies In Veterinary Health Market: Regional Estimates & Trend Analysis

  • 7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Japan
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. SWOT Analysis
    • 7.6.2. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participation Categorization
  • 8.2. Key Company Profiles
    • 8.2.1 Zoetis
    • 8.2.2 Merck & Co, Inc.
    • 8.2.3 Elanco
    • 8.2.4 Boehringer Ingelheim GmbH
    • 8.2.5 Indian Immunologicals Ltd
    • 8.2.6 Virbac
      • 8.2.6.1. Participant's Overview
      • 8.2.6.2. Product Benchmarking
      • 8.2.6.3. Financial Performance
      • 8.2.6.4. Strategy Mapping
  • 8.3. List of Other Players (inclusive of companies with pipeline products)

List of Tables

  • Table 1 Global Monoclonal Antibodies in Veterinary Health Market, by Region, 2018 - 2030 (USD Million)
  • Table 2 North America Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 4 North America Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 5 North America Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 6 US Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 7 US Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 8 US Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 9 Canada Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 10 Canada Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 11 Canada Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 12 Europe Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 13 Europe Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 14 Europe Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 15 Europe Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 16 Germany Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 17 Germany Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 18 Germany Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 19 UK Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 22 Spain Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 23 Spain Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 24 Spain Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 25 Italy Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 26 Italy Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 27 Italy Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 28 France Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 29 France Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 30 France Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 31 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 33 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 34 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 35 Japan Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 36 Japan Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 37 Japan Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 38 China Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 39 China Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 40 China Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 41 India Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 42 India Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 43 India Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 44 Australia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 45 Australia Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 46 Australia Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 47 South Korea Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 48 South Korea Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 49 South Korea Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 50 LATAM Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 51 LATAM Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 52 LATAM Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 53 LATAM Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 54 Brazil Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 55 Brazil Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 56 Brazil Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 57 Mexico Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 58 Mexico Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 59 Mexico Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 60 Argentina Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 61 Argentina Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 62 Argentina Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 63 MEA Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
  • Table 64 MEA Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 65 MEA Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 66 MEA Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 67 South Africa Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 68 South Africa Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 69 South Africa Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 70 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
  • Table 71 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Application
  • Table 72 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by End-User
  • Table 73 Participant's overview
  • Table 74 Financial performance
  • Table 75 Product Benchmarking
  • Table 76 Key companies undergoing strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Monoclonal Antibodies in Veterinary Health Market segmentation
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Ansoff's matrix analysis
  • Fig. 14 Heat map analysis
  • Fig. 15 Market penetration vs growth prospect mapping
  • Fig. 16 Market share of key market players- Monoclonal Antibodies in Veterinary Health Market
  • Fig. 17 Strategy mapping
  • Fig. 18 Monoclonal Antibodies in Veterinary Health Market animal type outlook: 2022
  • Fig. 19 Monoclonal Antibodies in Veterinary Health Market: animal type movement analysis
  • Fig. 20 Dogs market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Monoclonal Antibodies in Veterinary Health Market application outlook: 2022
  • Fig. 23 Monoclonal Antibodies in Veterinary Health Market: application movement analysis
  • Fig. 24 Dermatology market, 2018 - 2030 (USD Million)
  • Fig. 25 Pain market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Monoclonal Antibodies in Veterinary Health Market end-user outlook: 2022
  • Fig. 28 Monoclonal Antibodies in Veterinary Health Market: end-user movement analysis
  • Fig. 29 Veterinary Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Regional marketplace: 2022
  • Fig. 32 Regional outlook, 2018 & 2030
  • Fig. 33 North America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 44 China Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 45 India Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 46 Australia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 52 MEA Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
  • Fig. 55 Strategy framework
  • Fig. 56 Market participant categorization